# JAMA Ophthalmology : Nicotinamide and Primary Open-Angle Glaucoma in Ocular Hypertension

Page: https://stenobird.com/podcast/jama-network-1057758/jama-ophthalmology-nicotinamide-and-primary-open-angle-glaucoma-in-ocular-hypertension
Text version: https://stenobird.com/podcast/jama-network-1057758/jama-ophthalmology-nicotinamide-and-primary-open-angle-glaucoma-in-ocular-hypertension.md
Podcast: [JAMA Network](https://stenobird.com/podcast/jama-network-1057758)
Published: 2026-07-09T15:00:00+00:00
Episode link: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaophthalmol.2026.2914
Audio file: http://traffic.libsyn.com/jamaophthalmologyauthorinterviews/Nicotinamide_and_Primary_Open-Angle_Glaucoma_in_Ocular_Hypertension_1.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/jama-network-1057758/episodes/jama-ophthalmology-nicotinamide-and-primary-open-angle-glaucoma-in-ocular-hypertension
Duration seconds: 1264

## Resource

Interview with Iqbal Ike K. Ahmed, MD, and Jawad Muayad, MD, authors of Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension. Hosted by Neil Bressler, MD. Related Content: Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/jama-network-1057758/episodes/jama-ophthalmology-nicotinamide-and-primary-open-angle-glaucoma-in-ocular-hypertension/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/jama-network-1057758/jama-ophthalmology-nicotinamide-and-primary-open-angle-glaucoma-in-ocular-hypertension.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.